Nano-Bio Electrochemical Interfacing–Linking Cell Biology and Micro-Electronics

  • Y. Shacham-Diamand
  • R. Popovtzer
  • Y. Rishpon
Part of the Nanostructure Science and Technology book series (NST)


Integration of biological substance within electronic devices is an innovative and challenging area combining recent progress in molecular biology and micro technology. First, we introduce the concept of integrating living cells with Micro Electro Mechanical Systems (MEMS). Following a brief overview on “whole cell based biosensors” we describe the design, fabrication, and process of a biocompatible electrochemical “Lab-on-a-Chip” system. Demonstrating the application of electrochemical interfacing based whole cell bio chips, we present two different configurations: a. integration of prokaryotic cells (bacteria) for water toxicity detection, and b. integration of eukaryotic cells (human colon cancer cells) for rapid evaluation of the effectiveness of drug treatments. Both applications, with either microbes or mammalian cells integrated onto MEMS based biochips with liquid volume in the range of 100 nL–1 μL, function well and yield a detectable signal much higher than noise level after few minutes.


Colon Cancer Cell Butyric Acid Alkaline Phosphatase Activity Micro Electro Mechanical System Silicon Chip 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Belkin S (2003) Microbial whole-cell sensing systems of environmental pollutants. Curr Opin Microbiol 6(3):206–212CrossRefGoogle Scholar
  2. 2.
    Stenger DA et al (2001) Detection of physiologically active compounds using cell-based biosensors. Trends Biotechnol 19(8):304–309CrossRefGoogle Scholar
  3. 3.
    Rudolph AS, Reasor J (2001) Cell and tissue based technologies for environmental detection and medical diagnostics. Biosens Bioelectron 16(7–8):429–431CrossRefGoogle Scholar
  4. 4.
    Pancrazio JJ et al (1999) Development and application of cell-based biosensors. Ann Biomed Eng 27(6):697–711CrossRefGoogle Scholar
  5. 5.
    Popovtzer R, Neufeld T, Ron EZ, Rishpon J, Shacham-Diamand Y (2006) Electrochemical detection of biological reactions using a novel nano-bio-chip array. Sensor Actuator B-Chem 119(2):664–672CrossRefGoogle Scholar
  6. 6.
    Daunert S et al (2000) Genetically engineered whale-cell sensing systems: coupling biological recognition with reporter genes. Chem Rev 100(7):2705–2738CrossRefGoogle Scholar
  7. 7.
    Kohler S et al (2000) Detection of 4-chlorobenzoate using immobilized recombinant Escherichia coli reporter strains. Sensor Actuator B-Chem 70(1–3):139–144CrossRefGoogle Scholar
  8. 8.
    Biran I et al (1999) On-line monitoring of gene expression. Microbiology-Sgm 145:2129–2133CrossRefGoogle Scholar
  9. 9.
    Paitan Y et al (2003) On-line and in situ biosensors for monitoring environmental pollution. Biotechnol Adv 22(1–2):27–33CrossRefGoogle Scholar
  10. 10.
    Paitan Y et al (2004) Monitoring aromatic hydrocarbons by whole cell electrochemical biosensors. Anal Biochem 335(2):175–183CrossRefGoogle Scholar
  11. 11.
    Premkumar JR et al (2001) Antibody-based immobilization of bioluminescent bacterial sensor cells. Talanta 55(5):1029–1038CrossRefGoogle Scholar
  12. 12.
    Cha HJ et al (1999) Green fluorescent protein as a noninvasive stress probe in resting Escherichia coli cells. Appl Environ Microbiol 65(2):409–414Google Scholar
  13. 13.
    Nivens DE et al (2004) Bioluminescent bioreporter integrated circuits: potentially small, rugged and inexpensive whole-cell biosensors for remote environmental monitoring. J Appl Microbiol 96(1):33–46CrossRefGoogle Scholar
  14. 14.
    Sagi E et al (2003) Fluorescence and bioluminescence reporter functions in genetically modified bacterial sensor strains. Sensor Actuator B-Chem 90(1–3):2–8CrossRefGoogle Scholar
  15. 15.
    Grigsby PW, Corn BW (1992) Localized urethral tumors in women–Indications for conservative versus exenterative therapies. J Urol 147(6):1516–1520Google Scholar
  16. 16.
    McLeod H (2007) Graying anatomy? Toward molecular tumor characterization. Pharmacogenomics 8(1):15–16CrossRefGoogle Scholar
  17. 17.
    Guillemard V, Saragovi HU (2004) Novel approaches for targeted cancer therapy. Current Cancer Drug Targets 4(4):313–326CrossRefGoogle Scholar
  18. 18.
    Konski A, Feigenberg S, Chow E (2005) Palliative radiation therapy. Semin Oncol 32(2):156–164CrossRefGoogle Scholar
  19. 19.
    Cao T, Heng BC (2005) Differentiation therapy of cancer. Potential advantages over conventional therapeutic approaches targeting death of cancer/tumor cells. Med Hypotheses 65(6):1202–1203CrossRefGoogle Scholar
  20. 20.
    Miller SJ (2004) Cellular and physiological effects of short-chain fatty acids. Mini-Reviews in Medicinal Chemistry 4(8):839–845CrossRefGoogle Scholar
  21. 21.
    Sell S, Pierce GB (1994) Maturation arrest of stem-cell differentiation is a common pathway for the cellular-origin of teratocarcinomas and epithelial cancers. Lab Invest 70(1):6–22Google Scholar
  22. 22.
    Bell DR, Van Zant G (2004) Stem cells, aging, and cancer: inevitabilities and outcomes. Oncogene 23(43):7290–7296CrossRefGoogle Scholar
  23. 23.
    Patnaik A et al (2002) A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. Clin Canc Res 8(7):2142–2148Google Scholar
  24. 24.
    Rephaeli A, Zhuk R, Nudelman A (2000) Prodrugs of butyric acid from bench to bedside: Synthetic design, mechanisms of action, and clinical applications. Drug Dev Res 50(3–4):379–391CrossRefGoogle Scholar
  25. 25.
    Boren J et al (2003) The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation. J Biol Chem 278(31):28395–28402CrossRefGoogle Scholar
  26. 26.
    Newmark H, Lipkin M (1994) Omega-3-fatty-acids and rectal epithelial-cell proliferation. Gastroenterology 107(6):1892–1894Google Scholar
  27. 27.
    Comalada M et al (2007) The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype (vol 132, pg 487, 2006). J Cancer Res Clin Oncol 133(3):211–211CrossRefGoogle Scholar
  28. 28.
    Reid T et al (2004) Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer. Lung Cancer 45(3):381–386CrossRefGoogle Scholar
  29. 29.
    Pawitan Y et al (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7(6):R953–R964CrossRefGoogle Scholar
  30. 30.
    Entin-Meer M et al (2005) Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas. Mol Canc Therapeut 4(12):1952–1961CrossRefGoogle Scholar
  31. 31.
    Engel D et al (2005) Novel prodrugs of tegafur with antiangiogenic properties and improved anticancer activity. Clin Canc Res 11(24):9052S–9052SGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Faculty of EngineeringTel Aviv UniversityTel AvivIsrael
  2. 2.School of EngineeringBar-llan UniversityRamat GanIsrael

Personalised recommendations